Routine screening endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Endometrium Cell Line, Tumor Tumor Cells, Cultured Myometrium Lymph Nodes Pelvis Neoplastic Stem Cells

Organisms1

Diseases78

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Endometrial Hyperplasia Neoplasms Pancreatic Neoplasms Ovarian Neoplasms Uterine Neoplasms Neoplasm Invasiveness Breast Neoplasms Lung Neoplasms Adenocarcinoma Cystadenocarcinoma, Serous Genital Neoplasms, Female Neoplasms, Multiple Primary Carcinoma Prostatic Neoplasms Neoplasms, Second Primary Colonic Neoplasms Neoplasm Metastasis Colorectal Neoplasms, Hereditary Nonpolyposis Genetic Predisposition to Disease Stomach Neoplasms Adenocarcinoma, Clear Cell Cystadenocarcinoma, Papillary Neoplasm Recurrence, Local Skin Neoplasms Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Colorectal Neoplasms Adenocarcinoma, Mucinous Adenocarcinoma, Papillary Kidney Neoplasms Thyroid Neoplasms Liver Neoplasms Disease Progression Urinary Bladder Neoplasms Mixed Tumor, Mullerian Carcinoma, Squamous Cell Neoplasms, Hormone-Dependent Precancerous Conditions Carcinoma, Papillary Neoplasms, Radiation-Induced Gastrointestinal Neoplasms Cell Transformation, Neoplastic Neoplasms, Glandular and Epithelial Bone Neoplasms Vaginal Neoplasms Carcinosarcoma Microsatellite Instability Rectal Neoplasms Neoplasms, Experimental Mouth Neoplasms Uterine Hemorrhage Carcinoma, Pancreatic Ductal Testicular Neoplasms Adenoma Carcinoma, Non-Small-Cell Lung Esophageal Neoplasms Peritoneal Neoplasms Mixed Tumor, Mesodermal Obesity Head and Neck Neoplasms Carcinoma, Adenosquamous Myeloproliferative Disorders Neovascularization, Pathologic Pelvic Neoplasms Cystadenoma Polyps Intestinal Neoplasms Lymphoma Parotid Neoplasms Appendiceal Neoplasms Endocrine Gland Neoplasms Neoplasms, Connective and Soft Tissue Neoplasms, Plasma Cell Nose Neoplasms Cystadenoma, Mucinous

Chemicals and Drugs50

Tumor Markers, Biological Neoplasm Proteins Tamoxifen Estrogens DNA, Neoplasm Receptors, Progesterone Antineoplastic Agents, Hormonal Progestins Receptors, Estrogen Antineoplastic Agents RNA, Messenger Antigens, Neoplasm Estrogen Antagonists Contraceptives, Oral PTEN Phosphohydrolase MutS Homolog 2 Protein Cancer Vaccines Estrogen Receptor alpha Estrogen Receptor Modulators Selective Estrogen Receptor Modulators RNA, Small Interfering Tumor Suppressor Protein p53 Receptor, erbB-2 Nuclear Proteins Tumor Suppressor Proteins Paclitaxel RNA, Neoplasm DNA-Binding Proteins Adaptor Proteins, Signal Transducing Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt MicroRNAs Anticarcinogenic Agents Toremifene Cisplatin Antibodies, Monoclonal Estradiol TOR Serine-Threonine Kinases Arylsulfotransferase Raloxifene Antineoplastic Agents, Phytogenic CA-125 Antigen Phytoestrogens Contraceptives, Oral, Hormonal Ki-67 Antigen Prostate-Specific Antigen Aromatase Transcription Factors Estradiol Congeners Estrogens, Catechol

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Neoplasm Staging Early Detection of Cancer Hysterectomy Risk Factors Prognosis Case-Control Studies Risk Immunohistochemistry Retrospective Studies Prospective Studies Survival Rate Odds Ratio Follow-Up Studies Survival Analysis Estrogen Replacement Therapy Incidence Risk Assessment Reverse Transcriptase Polymerase Chain Reaction Sensitivity and Specificity Registries Neoplasm Grading Salpingectomy Cohort Studies Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Logistic Models Treatment Outcome Body Mass Index Blotting, Western Lymph Node Excision Neoplasm Transplantation Polymerase Chain Reaction Kaplan-Meier Estimate Immunoenzyme Techniques SEER Program Xenograft Model Antitumor Assays Multivariate Analysis Questionnaires Chemotherapy, Adjuvant Hormone Replacement Therapy Confidence Intervals Oligonucleotide Array Sequence Analysis Predictive Value of Tests Combined Modality Therapy Neoplasms, Experimental Reproducibility of Results Tissue Array Analysis Radiotherapy, Adjuvant Molecular Targeted Therapy Gynecologic Surgical Procedures Transplantation, Heterologous Obesity Drug Screening Assays, Antitumor Genetic Testing Clinical Trials as Topic Radiotherapy Biopsy DNA Mutational Analysis Dilatation and Curettage Tumor Burden Tomography, X-Ray Computed Transfection Gene Knockdown Techniques Flow Cytometry Reproductive History

Psychiatry and Psychology1

Phenomena and Processes44

Gene Expression Regulation, Neoplastic Risk Postmenopause Genetic Predisposition to Disease Odds Ratio Sensitivity and Specificity Mutation Genotype DNA Methylation Germ-Line Mutation Cell Proliferation Body Mass Index Drug Resistance, Neoplasm Menopause Polymorphism, Genetic Apoptosis Microsatellite Repeats Cell Growth Processes Gene Silencing Microsatellite Instability Premenopause Time Factors Parity Cell Division Down-Regulation Cell Survival Genes, Tumor Suppressor Cell Cycle Signal Transduction Dose-Response Relationship, Drug Obesity Promoter Regions, Genetic Diet DNA Mismatch Repair Base Sequence Cell Movement Alleles Polymorphism, Single Nucleotide Genes, Neoplasm Gene Expression Transfection Up-Regulation Phenotype Genes, p53

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Survival

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care32

Risk Factors Case-Control Studies Risk Retrospective Studies Prospective Studies Survival Rate Odds Ratio Follow-Up Studies Survival Analysis Incidence Risk Assessment Sensitivity and Specificity Registries Age Factors Cohort Studies Disease-Free Survival Logistic Models Treatment Outcome Body Mass Index Kaplan-Meier Estimate SEER Program Multivariate Analysis Questionnaires Confidence Intervals Predictive Value of Tests Reproducibility of Results Parity National Cancer Institute (U.S.)Genetic Testing Clinical Trials as Topic Confounding Factors (Epidemiology)Reproductive History

Geographicals4

United States Sweden China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Endometrial Hyperplasia Neoplasms Pancreatic Neoplasms Ovarian Neoplasms Uterine Neoplasms Neoplasm Staging Early Detection of Cancer Neoplasm Invasiveness Breast Neoplasms Hysterectomy Endometrium Risk Factors Prognosis Lung Neoplasms Adenocarcinoma Tumor Markers, Biological Gene Expression Regulation, Neoplastic Cystadenocarcinoma, Serous Case-Control Studies Risk Genital Neoplasms, Female Neoplasms, Multiple Primary Neoplasm Proteins Tamoxifen Carcinoma Cell Line, Tumor Immunohistochemistry Retrospective Studies Estrogens Prostatic Neoplasms Neoplasms, Second Primary Colonic Neoplasms Postmenopause Neoplasm Metastasis Colorectal Neoplasms, Hereditary Nonpolyposis DNA, Neoplasm Genetic Predisposition to Disease Stomach Neoplasms Prospective Studies Adenocarcinoma, Clear Cell Cystadenocarcinoma, Papillary Survival Rate Neoplasm Recurrence, Local Receptors, Progesterone Odds Ratio Follow-Up Studies Survival Analysis Skin Neoplasms Antineoplastic Agents, Hormonal Progestins Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Colorectal Neoplasms Estrogen Replacement Therapy Mice, Nude Incidence Receptors, Estrogen Risk Assessment Reverse Transcriptase Polymerase Chain Reaction Sensitivity and Specificity Registries Mutation United States Neoplasm Grading Antineoplastic Agents Salpingectomy Adenocarcinoma, Mucinous Age Factors Cohort Studies Adenocarcinoma, Papillary Kidney Neoplasms Genotype RNA, Messenger DNA Methylation Thyroid Neoplasms Liver Neoplasms Disease Progression Urinary Bladder Neoplasms Antigens, Neoplasm Disease-Free Survival Germ-Line Mutation Estrogen Antagonists Cell Proliferation Antineoplastic Combined Chemotherapy Protocols Contraceptives, Oral Gene Expression Profiling PTEN Phosphohydrolase Mixed Tumor, Mullerian Carcinoma, Squamous Cell Logistic Models Neoplasms, Hormone-Dependent Treatment Outcome Body Mass Index Blotting, Western Drug Resistance, Neoplasm Lymph Node Excision MutS Homolog 2 Protein

No FAQ available that match "routine screening endometrial cancer vulvar neoplasms"